CB Insights
Technology Market Intelligence
Technology Market Intelligence
Calithera Biosciences, formerly Protein Activation Therapeutics, develops therapeutic approaches to the treatment of cancer by using small molecules to activate, rather than inhibit, enzymes. The company's first program is focused on developing activ...Show all
Company (IPO / Went public)
Phone: 650-870-1000
343 Oyster Point Blvd
Suite 200
South San Francisco, 94080
California, United States
| Per Week | Per Month | Per 6 Months | Per Year | |
|---|---|---|---|---|
| Rank | Login to see details | |||
| Page Views Per Million | Login to see details | |||
| Page Views Per User | Login to see details | |||
| Reach Per Million | Login to see details | |||
| Title | Application Date | Patent Date | Status (Patent / Application) |
|---|---|---|---|
| Combination therapy with glutaminase inhibitors and immuno-oncology agents | Feb 01, 2019 | Mar 09, 2021 | Patent |
| Method of preparing (3r,4s)-3-acetamido-4-allyl-n-(tert-butyl)pyrrolidine-3-carboxamide | Nov 18, 2019 | Feb 02, 2021 | Patent |
| Compositions and methods for inhibiting arginase activity | Jul 29, 2019 | Feb 02, 2021 | Patent |
| Compositions and methods for inhibiting arginase activity | Aug 10, 2018 | Dec 01, 2020 | Patent |
| Compositions and methods for inhibiting arginase activity | Mar 23, 2020 | Nov 24, 2020 | Patent |
